Stagen Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Stagen General Information

Description

Provider of drug development services based in Taito City, Japan. The company offers healthcare devices, educational projects, clinical research, clinical trials, genome studies, drug development and repositioning services, thereby helping clients in making drug development more effective.

Contact Information

Website
www.stagen.co.jp
Formerly Known As
Tailor-aid Inc., Giar Map Inc.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • KUGA Building 8F 4-11-6
  • Tokyo
  • Taito City, 111-0051
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Parent Company
MTI (Japan)
Vertical(s)
Life Sciences
Corporate Office
  • KUGA Building 8F 4-11-6
  • Tokyo
  • Taito City, 111-0051
  • Japan
+81

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stagen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Stagen‘s full profile, request access.

Request a free trial

Stagen Patents

  • 84

    Total Documents Applications and Grants

  • Total Patents Families

  • 40

    Granted

  • 18

    Pending

  • Expiring in next 12 mo

Stagen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023170730-A Method for determining decline in mitochondria function Pending 20-May-2022
JP-2023025415-A Program, storage medium, system, learned model, and determination method Pending 10-Aug-2021
JP-2021161090-A Mitochondrion protective agent, mitochondrial disorder improver, or mitochondrial function improver Pending 02-Apr-2020
JP-2020201068-A Method of predicting effect of atp augmentation therapy to neurodegenerative disease Active 07-Jun-2019
JP-7333942-B2 Method for predicting effect of atp-enhancing therapy on neurodegenerative disease Active 07-Jun-2019 G01N33/50
To view Stagen’s complete patent history, request access »

Stagen Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Takaha Pharma Tokyo, Japan 2017

Stagen FAQs

  • When was Stagen founded?

    Stagen was founded in 1999.

  • Where is Stagen headquartered?

    Stagen is headquartered in Taito City, Japan.

  • What industry is Stagen in?

    Stagen’s primary industry is Drug Discovery.

  • Is Stagen a private or public company?

    Stagen is a Private company.

  • What is Stagen’s current revenue?

    The current revenue for Stagen is .

  • When was Stagen acquired?

    Stagen was acquired on 01-Nov-2015.

  • Who acquired Stagen?

    Stagen was acquired by MTI (Japan).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »